Press Releases
Quaker Chemical Announces Second Quarter 2016 Results
The Company's strong operating performance year-over-year was offset by a higher effective tax rate of 32.6% in the second quarter of 2016 compared to 27.1% in the second quarter of 2015, resulting in earnings per diluted share of
Second Quarter of 2016 Summary
Net sales in the second quarter of 2016 were
Gross profit in the second quarter of 2016 increased
Selling, general and administrative expenses ("SG&A") decreased less than
Operating income in the second quarter of 2016 was
Other income was
Interest expense was
The Company's effective tax rates for the second quarters of 2016 and 2015 were 32.6% and 27.1%, respectively. The increase in the second quarter of 2016 effective tax rate was primarily due to the Company recording earnings in one of its subsidiaries at a statutory tax rate of 25% while it awaits recertification of a concessionary 15% tax rate, which was available to the Company during the second quarter of 2015. For the same reason, the Company estimates its third quarter of 2016 effective tax rate will be between 29% and 31%. However, the Company still estimates its full year 2016 effective tax rate will approximate 28% to 30%.
Equity in net income of associated companies ("equity income") increased
Net income attributable to noncontrolling interest was relatively flat in the second quarter of 2016 compared to the prior year quarter.
Changes in foreign exchange rates negatively impacted the Company's second quarter of 2016 net income by approximately 4%, or
Year-to-Date 2016 Summary
Net sales in the first six months of 2016 were
Gross profit in the first six months of 2016 increased
SG&A increased
Operating income in the first six months of 2016 was
Other income was
Interest expense was
The Company's effective tax rates for the first six months of 2016 and 2015 were 32.5% and 28.8%, respectively. The increase in the first six months of 2016 effective tax rate was primarily due to the Company recording earnings in one of its subsidiaries at a statutory tax rate of 25% while it awaits recertification of a concessionary 15% tax rate, which was available to the Company during the first six months of 2015, as noted above.
Equity income increased
The Company had a
Changes in foreign exchange rates, excluding the currency conversion impacts of the Venezuelan bolivar fuerte, noted above, negatively impacted the Company's first six months of 2016 net income by approximately 3%, or
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of approximately
Non-GAAP Measures
Included in this public release are two non-GAAP (unaudited) financial measures: non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. The following tables reconcile non-GAAP earnings per diluted share (unaudited) and adjusted EBITDA (unaudited) to their most directly comparable GAAP (unaudited) financial measures:
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||
2016 |
2015 |
2016 |
2015 |
|||||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders |
$ 1.13 |
$ 1.13 |
$ 2.11 |
$ 1.90 |
||||||
Equity (income) loss in a captive insurance company per diluted share |
(0.02) |
0.01 |
(0.03) |
(0.05) |
||||||
U.S. customer bankruptcy per diluted share |
— |
0.01 |
— |
0.01 |
||||||
Cost streamlining initiatives per diluted share |
— |
— |
— |
0.01 |
||||||
Currency conversion impact of the Venezuelan bolivar fuerte per diluted share |
— |
— |
0.01 |
0.21 |
||||||
Non-GAAP earnings per diluted share |
$ 1.11 |
$ 1.15 |
$ 2.09 |
$ 2.08 |
||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||
2016 |
2015 |
2016 |
2015 |
|||||||
Net income attributable to Quaker Chemical Corporation |
$ 15,015 |
$ 15,038 |
$ 27,961 |
$ 25,416 |
||||||
Depreciation and amortization |
4,986 |
4,666 |
9,920 |
9,364 |
||||||
Interest expense |
727 |
607 |
1,468 |
1,194 |
||||||
Taxes on income before equity in net income of associated companies |
7,238 |
5,724 |
13,543 |
11,083 |
||||||
Equity (income) loss in a captive insurance company |
(303) |
100 |
(355) |
(695) |
||||||
U.S. customer bankruptcy |
— |
111 |
— |
111 |
||||||
Cost streamlining initiatives |
— |
— |
— |
173 |
||||||
Currency conversion impact of the Venezuelan bolivar fuerte |
— |
— |
88 |
2,806 |
||||||
Adjusted EBITDA |
$ 27,663 |
$ 26,246 |
$ 52,625 |
$ 49,452 |
||||||
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
|||||||
Condensed Consolidated Statements of Income |
|||||||
(Dollars in thousands, except share and per share data) |
|||||||
(Unaudited) |
|||||||
Three Months Ended June 30 |
Six Months Ended June 30 |
||||||
2016 |
2015 |
2016 |
2015 |
||||
Net sales |
$ 186,915 |
$ 183,726 |
$ 364,992 |
$ 365,056 |
|||
Cost of goods sold |
115,680 |
113,109 |
225,882 |
228,111 |
|||
Gross profit |
71,235 |
70,617 |
139,110 |
136,945 |
|||
% |
38.1% |
38.4% |
38.1% |
37.5% |
|||
Selling, general and administrative expenses |
49,142 |
49,172 |
97,783 |
97,636 |
|||
Operating income |
22,093 |
21,445 |
41,327 |
39,309 |
|||
% |
11.8% |
11.7% |
11.3% |
10.8% |
|||
Other income (expense), net |
271 |
(88) |
977 |
(282) |
|||
Interest expense |
(727) |
(607) |
(1,468) |
(1,194) |
|||
Interest income |
545 |
375 |
893 |
695 |
|||
Income before taxes and equity in net income of associated companies |
22,182 |
21,125 |
41,729 |
38,528 |
|||
Taxes on income before equity in net income of associated companies |
7,238 |
5,724 |
13,543 |
11,083 |
|||
Income before equity in net income of associated companies |
14,944 |
15,401 |
28,186 |
27,445 |
|||
Equity in net income (loss) of associated companies |
461 |
11 |
563 |
(1,426) |
|||
Net income |
15,405 |
15,412 |
28,749 |
26,019 |
|||
Less: Net income attributable to noncontrolling interest |
390 |
374 |
788 |
603 |
|||
Net income attributable to Quaker Chemical Corporation |
$ 15,015 |
$ 15,038 |
$ 27,961 |
$ 25,416 |
|||
% |
8.0% |
8.2% |
7.7% |
7.0% |
|||
Share and per share data: |
|||||||
Basic weighted average common shares outstanding |
13,126,134 |
13,220,264 |
13,121,470 |
13,204,599 |
|||
Diluted weighted average common shares outstanding |
13,144,713 |
13,239,675 |
13,136,653 |
13,223,850 |
|||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 1.13 |
$ 1.13 |
$ 2.11 |
$ 1.91 |
|||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 1.13 |
$ 1.13 |
$ 2.11 |
$ 1.90 |
|||
Quaker Chemical Corporation |
|||
Condensed Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value and share amounts) |
|||
(Unaudited) |
|||
June 30, |
December 31, |
||
2016 |
2015 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 96,245 |
$ 81,053 |
|
Accounts receivable, net |
184,306 |
188,297 |
|
Inventories, net |
78,269 |
75,099 |
|
Prepaid expenses and other current assets |
23,905 |
21,404 |
|
Total current assets |
382,725 |
365,853 |
|
Property, plant and equipment, net |
85,094 |
87,619 |
|
Goodwill |
79,324 |
79,111 |
|
Other intangible assets, net |
71,530 |
73,287 |
|
Investments in associated companies |
22,324 |
20,354 |
|
Non-current deferred tax assets |
19,082 |
23,468 |
|
Other assets |
32,217 |
32,218 |
|
Total assets |
$ 692,296 |
$ 681,910 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 672 |
$ 662 |
|
Accounts and other payables |
75,569 |
71,543 |
|
Accrued compensation |
14,456 |
19,166 |
|
Accrued restructuring |
4,080 |
6,303 |
|
Other current liabilities |
24,536 |
26,881 |
|
Total current liabilities |
119,313 |
124,555 |
|
Long-term debt |
83,601 |
81,439 |
|
Non-current deferred tax liabilities |
11,748 |
11,400 |
|
Other non-current liabilities |
77,401 |
83,273 |
|
Total liabilities |
292,063 |
300,667 |
|
Equity |
|||
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2016 - 13,249,759 shares; 2015 - 13,288,113 shares |
13,250 |
13,288 |
|
Capital in excess of par value |
109,751 |
106,333 |
|
Retained earnings |
340,127 |
326,740 |
|
Accumulated other comprehensive loss |
(71,790) |
(73,316) |
|
Total Quaker shareholders' equity |
391,338 |
373,045 |
|
Noncontrolling interest |
8,895 |
8,198 |
|
Total equity |
400,233 |
381,243 |
|
Total liabilities and equity |
$ 692,296 |
$ 681,910 |
Quaker Chemical Corporation |
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
(Unaudited) |
|||
Six Months Ended June 30, |
|||
2016 |
2015 |
||
Cash flows from operating activities |
|||
Net income |
$ 28,749 |
$ 26,019 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||
Depreciation |
6,331 |
6,117 |
|
Amortization |
3,589 |
3,247 |
|
Equity in undistributed (earnings) losses of associated companies, net of dividends |
(488) |
1,487 |
|
Deferred compensation and other, net |
3,609 |
1,325 |
|
Stock-based compensation |
3,423 |
3,169 |
|
Loss (gain) on disposal of property, plant, equipment and other assets |
45 |
(69) |
|
Insurance settlement realized |
(614) |
(301) |
|
Pension and other postretirement benefits |
(2,896) |
1,019 |
|
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions: |
|||
Accounts receivable |
3,801 |
(2,344) |
|
Inventories |
(2,387) |
(1,993) |
|
Prepaid expenses and other current assets |
(3,164) |
(4,057) |
|
Accounts payable and accrued liabilities |
(1,642) |
(6,301) |
|
Change in restructuring liabilities |
(2,330) |
- |
|
Net cash provided by operating activities |
36,026 |
27,318 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(4,377) |
(4,277) |
|
Payments related to acquisitions, net of cash acquired |
(3,284) |
528 |
|
Proceeds from disposition of assets |
48 |
102 |
|
Insurance settlement interest earned |
16 |
20 |
|
Change in restricted cash, net |
598 |
281 |
|
Net cash used in investing activities |
(6,999) |
(3,346) |
|
Cash flows from financing activities |
|||
Proceeds from long-term debt |
1,736 |
- |
|
Repayment of long-term debt |
(286) |
(12,699) |
|
Dividends paid |
(8,480) |
(7,991) |
|
Stock options exercised, other |
(95) |
534 |
|
Payments for repurchase of common stock |
(5,859) |
(1,630) |
|
Excess tax benefit related to stock option exercises |
136 |
378 |
|
Net cash used in financing activities |
(12,848) |
(21,408) |
|
Effect of foreign exchange rate changes on cash |
(987) |
(1,511) |
|
Net increase in cash and cash equivalents |
15,192 |
1,053 |
|
Cash and cash equivalents at the beginning of the period |
81,053 |
64,731 |
|
Cash and cash equivalents at the end of the period |
$ 96,245 |
$ 65,784 |
|
Logo - http://photos.prnewswire.com/prnh/20120910/PH70044LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quaker-chemical-announces-second-quarter-2016-results-300304977.html
SOURCE
Mary Dean Hall, Vice President, Chief Financial Officer and Treasurer, Hallm@quakerchem.com, T. 610.832.4160